| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1372720 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
Several novel spiropiperidine-based CGRP receptor antagonists have been developed that maintain good potency and have reduced potential for metabolism.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Christopher S. Burgey, Craig M. Potteiger, James Z. Deng, Scott D. Mosser, Christopher A. Salvatore, Sean Yu, Shane Roller, Stefanie A. Kane, Joseph P. Vacca, Theresa M. Williams,